CONMED Corporation
Moat Score — CONMED Corporation
Total Moat Score
11 / 30
| Moat Factor | Score | Analysis |
|---|---|---|
| Intangible Assets Patents, trademarks, brand strength, or regulatory licenses that protect a company's products or services from being freely copied by competitors. | 2 / 5 | CONMED holds patents and clinically established brands (AirSeal, BioBrace, Buffalo Filter) that provide some differentiation, but it lacks the breadth of IP and regulatory approvals held by scale competitors like Stryker or Medtronic. |
| Cost Advantage A durable ability to produce goods or services more cheaply than competitors — through scale, unique access to cheap inputs, location, or process — that lets a company undercut rivals or out-earn them at the same price. | 1 / 5 | At roughly $1.4 billion in revenue, CONMED lacks the manufacturing and purchasing scale of much larger rivals, leaving it at a relative cost disadvantage rather than possessing a structural cost edge. |
| Pricing Power The ability to raise prices without losing meaningful business, because the product or service is differentiated, mission-critical, or has few good substitutes. | 2 / 5 | Differentiated single-use platforms support some pricing durability, but hospital group purchasing organizations and larger bundled competitors constrain CONMED's ability to consistently raise prices. |
| Network Effect The product or service becomes more valuable to every user as more people or organizations use it, making an established leader harder to displace. | 1 / 5 | Medical device markets exhibit minimal true network effects; any benefit is limited to surgeon community familiarity and technique-sharing around specific CONMED platforms. |
| Switching Costs The money, time, or operational disruption a customer would face switching to a competitor, which locks in existing customers and supports renewals. | 3 / 5 | Surgeon training, OR staff familiarity, and instrument-specific technique adoption (e.g., AirSeal, BioBrace) create meaningful switching friction once a hospital and surgical team standardize on a platform. |
| Efficient Scale A market that can only profitably support a small number of players, so incumbents face limited threat from new entrants even without other defenses. | 2 / 5 | CONMED holds solid share in focused niches like insufflation and smoke evacuation, but these markets are not natural limited-competitor niches, and larger diversified players continue to contest them. |